Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Minerva Neurosciences Inc
NERVCurrent price
2.95 USD
+0.2 USD (+7.27%)
Last closed
2.75 USD
Company
www.minervaneurosciences.com
ISIN
US6033801068
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
18 252 800 USD
Yield for 12 month
-62.66 %
1Y
3Y
5Y
10Y
15Y
NERV
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts. Address: 1500 District Avenue, Burlington, MA, United States, 01803
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-30 982 USD
Last Year
-8 513 USD
Current Quarter
-7 746 USD
Last Quarter
-7 745 USD
Key Figures NERV
1 year
3 years
5 years
10 years
EBITDA
-26 205 152 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-28.88 %
PEG Ratio
–
Return On Equity TTM
-675.09 %
Wall Street Target Price
5 USD
Revenue TTM
–
Book Value
-6.36 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
-16 838 947 USD
Earnings per share
-4.4 USD
Diluted Eps TTM
-4.4 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics NERV
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NERV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:8
Payout Ratio
–
Last Split Date
21.06.2022
Dividend Date
–
Stock Valuation NERV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
11.2108
Enterprise Value Revenue
0.0345
Price Sales TTM
1.868
Enterprise Value EBITDA
2.6004
Price Book MRQ
2.6783
Financials NERV
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NERV
For 52 weeks
2.26 USD
13.49 USD
50 Day MA
2.96 USD
Shares Short Prior Month
13 675
200 Day MA
4.3 USD
Short Ratio
0.66
Shares Short
12 152
Short Percent
0.31 %
BeatStart